Source: http://www.google.es/patents/US9125550
Timestamp: 2017-12-18 03:34:11
Document Index: 555325649

Matched Legal Cases: ['Application No. 2', 'Application No. 05', 'Application No. 05', 'Application No. 05', 'Application No. 11', 'Application No. 2007']

Patente US9125550 - Tissue resecting system - Google Patentes
A surgical system includes a first instrument defining a first channel and a second instrument receivable by the first channel. The second instrument defines a second channel. A valve coupled to the first instrument controls fluid flow through the first channel, such that impedance of fluid flow through...http://www.google.es/patents/US9125550?utm_source=gb-gplus-sharePatente US9125550 - Tissue resecting system
Número de publicación US9125550 B2
Número de solicitud US 14/473,389
Fecha de presentación 29 Ago 2014
También publicado como CA2578035A1, CA2578035C, EP1796530A2, EP2508119A2, EP2508119A3, US8062214, US8419626, US8852085, US20060047185, US20110301623, US20130225928, US20140371708, US20150327752, US20160220102, WO2006026236A2, WO2006026236A3
Número de publicación 14473389, 473389, US 9125550 B2, US 9125550B2, US-B2-9125550, US9125550 B2, US9125550B2
Inventores Cemal Shener-Irmakoglu, Christopher R. Newell, Petter Hedstrom, Kenneth W. Krause
Citas de patentes (307), Otras citas (117), Citada por (2), Clasificaciones (16), Eventos legales (2)
US 9125550 B2
1. A method of providing fluid to a distensible organ, the method comprising:
(a) positioning a valve body within a housing of a valve of a first instrument in a first position;
(b) introducing fluid to the distensible organ through the valve body with the valve body in the first position and through a channel in the first instrument;
(c) positioning the valve body in a second position;
(d) introducing a second instrument through the valve body with the valve body in the second position and through the channel of the first instrument; and
(e) introducing fluid to the distensible organ through the valve body with the valve body in the second position and through a region of the channel of the first instrument located between the first instrument and the second instrument,
wherein an impedance of fluid flow in elements (b) and (e) is substantially equal.
the valve body defines an opening,
with the valve body in the first position, the opening is not aligned with the channel of the first instrument, and
with the valve body in the second position, the opening is aligned with the channel of the first instrument.
3. The method of claim 2, wherein the opening provides a first predefined impedance to fluid flow through the valve body when the valve body is in the first position and the opening provides a second predefined impedance to fluid flow through the valve body when the valve body is in the second position.
4. The method of claim 1, wherein the first instrument includes an outer member and an inner member, the inner member defining the channel of the first instrument therethrough, the inner member being received within the outer member, and the outer member and the inner member defining a second channel of the first instrument therebetween.
5. The method of claim 4, wherein the second instrument includes a tube defining a first channel of the second instrument therethrough, the tube partially blocking the channel of the first instrument when received therein.
an elongated member defining an inflow channel and being configured to accept an instrument inserted therethrough and be inserted into a patient; and
a valve assembly coupled to a proximal end of the elongated member and including: (i) a valve housing having a valve inlet in fluid communication with a fluid source and a valve outlet coupled to the elongated member and in fluid communication with the inflow channel, and (ii) a valve body rotatable within the valve housing between the valve inlet and the valve outlet to regulate an impedance of fluid flow through the endoscope, the valve body defining a throughbore and a blind bore that is perpendicular to and in fluid communication with the throughbore.
7. The endoscope of claim 6, wherein a first position of the valve body includes the throughbore being aligned with the valve inlet and the blind bore being aligned with the valve outlet, and a second position of the valve body includes the throughbore being aligned with the valve outlet and the blind bore being aligned with the valve inlet.
8. The endoscope of claim 7, wherein the valve housing further includes a resector inlet, and the throughbore is aligned with the resector inlet when the valve body is in the second position.
9. The endoscope of claim 8, wherein a first impedance of fluid flow through the valve housing with the valve body in the first position is substantially equal to a second impedance of fluid flow through the valve housing with the valve body in the second position and with a resector extending into the resector inlet, through the throughbore, and into the inflow channel of the elongated member.
10. The endoscope of claim 8, wherein the valve assembly further includes a second valve including: (i) a second valve housing having a second valve inlet configured to receive fluid from the fluid source and a second valve outlet configured to flow fluid to the valve inlet of the valve, and (ii) a second valve body rotatable within the second valve housing between the second valve inlet and the second valve outlet to provide ON/OFF fluid control for the endoscope, and a diameter of the resector inlet is smaller than a diameter of the throughbore.
an endoscope including an elongated member and a valve assembly, the elongated member including an inner wall defining an inflow channel and being configured to be inserted into a patient, the valve assembly being coupled to the elongated member at a proximal end of the endoscope and including: (i) an inflow port coupled to a fluid outlet line to receive, (ii) a first valve coupled to the inflow port to provide ON/OFF control of the fluid flow from the inflow port, and (iii) a second valve coupled between the first valve and the elongated member; and
a resector operable to be selectively inserted through the second valve and through the elongated member within the inflow channel,
wherein the second valve is configured in a first position to partially define a first fluid path through the valve assembly, the second valve is configured in a second position to partially define a second fluid path through the valve assembly, and impedances of the fluid flow through the first fluid path and the second fluid path, when the resector is positioned through the second valve, are substantially equal.
12. The endoscope system of claim 11, wherein the second valve includes a valve housing, including an inlet and an outlet, and a valve body rotatable within the valve housing between the inlet and the outlet, the valve body defining a throughbore and a blind bore that is perpendicular to and in fluid communication with the throughbore, a first end of the throughbore is contiguous to the inlet and the blind bore is aligned with the outlet with the second valve in the first position, and the blind bore is aligned with the inlet and a second end of the throughbore is contiguous to the outlet with the second valve in the second position.
13. The endoscope system of claim 12, wherein the resector includes an outer tube, the first fluid path is partially defined by the first end of the throughbore and the blind bore, and the second fluid path is partially defined by the blind bore and a space defined by the throughbore and the outer tube of the resector.
14. The endoscope system of claim 12, wherein a longitudinal axis of the throughbore is offset from a longitudinal axis of the blind bore.
15. The endoscope system of claim 12, wherein:
with the second valve in the first position, part of the valve body blocks the inlet to cause, at least in part, a first impedance,
with the second valve in the second position, the resector causes, at least in part, a second impedance, and
the first impedance and the second impedance are substantially equal.
16. The endoscope system of claim 11, further comprising:
a fluid management control unit configured to control fluid flow through the endoscope system, the fluid management control unit including the fluid outlet line.
17. A method of using an endoscope, the endoscope including an elongated member defining an inflow channel and a valve assembly coupled to a proximal end of the elongated member, the valve assembly including a first valve and a second valve, the first valve including: (i) a first valve housing including a first valve inlet configured to receive fluid from a fluid source and a first valve outlet, and (ii) a first valve body rotatable within the first valve housing between the first valve inlet and the first valve outlet, and the second valve including: (i) a second valve housing including a second valve inlet in fluid communication with the first valve outlet and a second valve outlet coupled to the elongated member and in fluid communication with the inflow channel, and (ii) a second valve body rotatable within the second valve housing between the second valve inlet and the second valve outlet, the second valve body defining a throughbore and a blind bore that is perpendicular to and in fluid communication with the throughbore, the method comprising:
(a) with the second valve body in a first position, flowing fluid through the first valve to the second valve, then through the throughbore to the blind bore, and then through the blind bore to the inflow channel;
(b) positioning the second valve body in a second position to accept an instrument through the throughbore of the second valve body and into the inflow channel; and
(c) with the second valve body in the second position and the instrument in the throughbore, flowing fluid through the first valve to the second valve, then through the blind bore and to the throughbore, and then through a lumen defined by an inner surface of the throughbore and an outer surface of the instrument,
wherein impedances of flowing fluid in elements (a) and (c) are substantially equal.
18. The method of using the endoscope of claim 17, wherein part of the second valve body blocks the second valve inlet to cause a first impedance of the flowing fluid of element (a), the instrument causes a second impedance of the flowing fluid of element (c), and the first impedance and the second impedance are substantially equal.
19. The method of using the endoscope of claim 17, the method further comprising, prior to element (a):
inserting the elongated member into a patient; and
flowing fluid from the fluid source to the second valve by positioning the first valve body in an ON position.
20. The method of using the endoscope of claim 17, wherein a longitudinal axis of the throughbore is offset from a longitudinal axis of the blind bore.
21. The method of using the endoscope of claim 17, wherein the second valve inlet includes an instrument inlet, and a diameter of the instrument inlet is less than a diameter of the throughbore.
an elongated member including an inner wall defining an inflow channel and being configured to be inserted into a patient and accept an instrument inserted therethrough; and
a valve assembly in fluid communication with the inflow channel and including a valve housing and a valve body, the valve housing including a valve inlet coupled to a fluid inlet line and a valve outlet coupled to a proximal end of the elongated member, and the valve body being within the valve housing between the valve inlet and the valve outlet and being rotatable to selectively define a first fluid path and a second fluid path through the endoscope.
23. The endoscope of claim 22, wherein an impedance of fluid flow through the endoscope without the instrument inserted therethrough and with the valve body defining the first fluid path is substantially equal to an impedance of fluid flow through the endoscope with the instrument inserted therethrough and with the valve body defining the second fluid path.
24. The endoscope of claim 22, wherein the valve body in a first position partially defines the first fluid path, and the valve body in a second position partially defines the second fluid path.
25. The endoscope of claim 24, wherein the valve body is rotated 90 degrees between the first position and the second position.
26. The endoscope of claim 22, wherein the valve body defines an angled bore.
This application is a continuation of prior application Ser. No. 13/860,654, filed Apr. 11, 2013, now allowed, which is a continuation of prior application Ser. No. 13/212,240, filed Aug. 18, 2011, now U.S. Pat. No. 8,419,626, which is a continuation of prior application Ser. No. 10/927,244, filed Aug. 27, 2004, now U.S. Pat. No. 8,062,214, each of which is hereby incorporated by reference herein in its entirety.
US5810770 * 13 Dic 1996 22 Sep 1998 Stryker Corporation Fluid management pump system for surgical procedures
JPH0175416U Título no disponible
6 Baggish et al., "Diagnostic and Operative Hysterectomy," Mosby, pp. 97-105, 123-125, 127132, 353-355, and 394-398, 1999 (27 pages).
8 Canadian Application No. 2,578,035, Office Action mailed Nov. 21, 2014 (4 pages).
9 Cravello et al., "Hysteroscopic Resection of Fibroids: Results with a 6-Year Follow-up Period", Journal of Gynecologic Surgery, vol. 15, No. 1, 1-5 1999 (5 pages).
10 Defendant Hologic Inc.'s Preliminary, Non-Binding List of Asserted Prior Art References, dated Feb. 8, 2012, in Smith & Nephew, Inc. v. Hologic, Inc., Civil Action Nos. 11-12064-RWZ and 10-10951-RWZ, U.S. District Court for the District of Massachusetts (7 pages).
11 Dictionary definition of reciprocate, Merrian-Webster Dictionary, on-line edition, retrieved Mar. 20, 2013 (1 page).
12 Dictionary definition of rotate, Merriam-Webster Dictionary, on-line edition, retrieved Mar. 20, 2013 (1 page).
13 Dictionary definition of translate, Merriam-Webster Dictionary, on-line edition, retrieved Mar. 20, 2013 (1 page).
14 Drews et al., "Surgical Approach to Myomas: Laparoscopy and Hysteroscopy", Seminars in Reproductive Endocrinology, vol. 10, No. 4, pp. 367-377, 1992 (11 pages).
15 Dumesic et al., "A New Approach to Hysteroscopic Cannulation of the Fallopian Tube", Journal of Gynecologic Surgery, vol. 7, No. 1, pp. 7-9, 1991 (3 pages).
16 Emanuel et al., "Long-term Results of Hysteroscopic Myomectomy for Abnormal Uterine Bleeding", Obstetrics & Gynecoogy, vol. 93, No. 5, Part I, pp. 743-748, 1999 (6 pages).
17 European Application No. 05 786 521.4, Office Action mailed Mar. 11, 2015, 4 pages.
18 European Patent Application No. 05 786 521.4-2305, Examination Report dated Apr. 21, 2010 (4 pages).
19 European Patent Application No. 05 786 521.4-2305, Examination Report dated Sep. 26, 2012 (5 pages).
20 European Patent Application No. 11 770 261.3-1657, Examination Report dated Feb. 11, 2014 (4 pages).
21 Exhibit P to Hologic's Opposition to Smith & Nephew's Motion for Preliminary Injunction, Redacted, filed Dec. 30, 2011, in Smith & Nephew, Inc. v. Hologic, Inc., Civil Action No. 11-12064-RWZ, U.S. District Court for the District of Massachusetts (99 pages).
22 Franchini et al., "Endometrial resection: a diagnostic tool in postmenopausal women", Gynecological Endoscopy, 8, pp. 111-114, 1999 (5 pages).
23 Gerber et al., "The Endoscapel: A new endoscopic instrument for supracervical hysterectomy and morcellation of masses; clinical evaluation", European Journal of Obstetrics & Gynecology and Reproductive Biology, 86, p. S12, 1999 (1 page).
24 Gynecare "Motor Drive Unit" Instructions for Use (3 pages).
25 Gynecare X-Tract, "Tissue Morcellator", Instructions for Use (3 pages).
26 Gynecare, "Fluid Management System" Instructions for Use (26 pages).
27 Gynescope Corporation "Laser Fiber Director", Advertisement, Journal of Gynecologic Surgery, vol. 6, No. 1, 1990 (2 pages).
28 Hess et al., "Textbook of Bilio-Pancreatic Disease", vol. III, PICCIN, e.g. Fig 6.5.1, pp. 1584-1586, 1997 (5 pages).
29 Hologic's Opposition to Smith & Nephew's Motion for Preliminary Injunction, Redacted, filed Dec. 30, 2011, in Smith & Nephew, Inc. v. Hologic, Inc., Civil Action No. 11-12064-RWZ, U.S. District Court for the District of Massachusetts (26 pages).
30 International Application No. PCT/US2005/029807, International Preliminary Report on Patentability dated Feb. 28, 2007 (9 pages).
31 International Application No. PCT/US2005/029807, International Search Report mailed on Jun. 13, 2006 (5 pages).
32 International Application No. PCT/US2011/053753, International Preliminary Report on Patentability dated Apr. 2, 2013 (7 pages).
33 International Application No. PCT/US2011/053753, International Search Report mailed on Dec. 20, 2011 (4 pages).
34 Japanese Patent Application No. 2007-530014, Translation of Office Action dated Feb. 15, 2011 (10 pages).
35 Karl Storz "Pilot A Course to Successful Outcomes", Intermetro Industries Corporation, 2001 (2 pages).
36 Karl Storz "Uterine Resectoscopes for Endometrial Ablation and Resection", Advertisement, Journal of Gynecologic Surgery, vol. 6, No. 1, 1990 (3 pages).
37 Karl Storz, Advertisement, Journal of Gynecologic Surgery, vol. 5, No. 4, 1989 (3 pages).
38 Lin et al. "Clinical Applications of a New Fujinon Operating Fiberoptic Hysteroscope", Journal of Gynecologic Surgery, vol. 6, No. 2, pp. 81-87, 1990 (7 pages).
39 Mettler et al., "Pelviscopic uterine surgery" Surgical Endoscopy, 6, pp. 23-31, 1992 (9 pages).
40 Neis et al., "Hysteroscopy: Textbook and Atlas", Thieme Medical Publishers, pp. 91-103, 1994 (13 pages).
41 Nisolle et al., "Endometrial ablation with the Nd-YAG laser in dysfunctional bleeding" Minimally Invasive Therapy, vol. 1, pp. 35-39, 1991 (5 pages).
42 Olympus Product Catalogue: Part No. A2461-OP Nephroscope, Sep. 1991 (3 pages).
43 Park et al., "Endoscopic Management of Uterine Myoma", Yonsei Medical Journal, vol. 40, No. 6, pp. 583-588, 1999 (6 pages).
44 Reexamination No. 95/001,933, Action Closing Prosecution mailed Sep. 19, 2013 (41 pages).
45 Reexamination No. 95/001,933, Appendices 14-28 to Request for Inter Partes Reexamination of U.S. Patent No. 7,226,459, Claim Charts for Various Claims in view of Various References (436 pages).
46 Reexamination No. 95/001,933, Appendix 2 to Request for Inter Partes Reexamination of U.S. Patent No. 7,226,459, Memorandum of Decision dated Apr. 21, 2011, in Smith & Nephew, Inc. v. Interlace Medical, Inc., Civil Action No. 10-10951-RWZ, U.S. District Court for the District of Massachusetts (14 pages).
47 Reexamination No. 95/001,933, Appendix 6 to Request for Inter Partes Reexamination of U.S. Patent No. 7,226,459, Opening Markman Brief of Plaintiff Smith & Nephew, Inc. dated Oct. 13, 2010, in Smith & Nephew, Inc. v. Interlace Medical, Inc., Civil Action No. 10-10951-RWZ, U.S. District Court for the District of Massachusetts (23 pages).
48 Reexamination No. 95/001,933, Appendix 7 to Request for Inter Partes Reexamination of U.S. Patent No. 7,226,459, Defendant Interlace Medical, Inc's Responsive Markman Brief (Redacted) dated Oct. 27, 2010, in Smith & Nephew, Inc. v. Interlace Medical, Inc., Civil Action No. 10-10951-RWZ, U.S. District Court for the District of Massachusetts (26 pages).
49 Reexamination No. 95/001,933, Appendix 8 to Request for Inter Partes Reexamination of U.S. Patent No. 7,226,459, Plaintiff Smith & Nephew, Inc.'s Reply in Support of Markman Brief dated Nov. 3, 2010, in Smith & Nephew, Inc. v. Interlace Medical, Inc., Civil Action No. 10-10951-RWZ, U.S. District Court for the District of Massachusetts (8 pages).
50 Reexamination No. 95/001,933, Examiner's Answer mailed Mar. 25, 2015 (3 pages).
51 Reexamination No. 95/001,933, Executed Expert Declaration of Hal Walbrink in support of Request for Inter Partes Reexamination of U.S. Patent No. 7,226,459, Executed Mar. 9, 2012 (42 pages).
52 Reexamination No. 95/001,933, First Office Action mailed Jun. 5, 2012 (37 pages).
53 Reexamination No. 95/001,933, Litigation Search Report CRU 3999 dated Mar. 29, 2012 (24 pages).
54 Reexamination No. 95/001,933, Order Granting Request for Reexamination mailed Jun. 5, 2012 (29 pages).
55 Reexamination No. 95/001,933, Patent Owner's Apr. 14, 2014 Appeal Brief (334 pages).
60 Reexamination No. 95/001,933, Right of Appeal Notice mailed Jan. 14, 2014 (58 pages).
61 Reexamination No. 95/001,933, Second Office Action mailed Apr. 1, 2013 (56 pages).
62 Reexamination No. 95/001,933, Third Party's Dec. 19, 2012 Response to Notification of Defective Paper and Comments on First Office Action mailed Jun. 5, 2012 (38 pages).
63 Reexamination No. 95/001,933, Third Party's Jul. 3, 2013 Comments on Second Office Action mailed Apr. 1, 2013 (62 pages).
64 Reexamination No. 95/001,933, Third Party's Mar. 12, 2012 Request for Inter Partes Reexamination of U.S. Patent No. 7,226,459 (130 pages).
65 Reexamination No. 95/001,933, Third Party's May 14, 2014 Respondent's Brief (303 pages).
66 Reexamination No. 95/001,933, Third Party's Nov. 20, 2013 Comments on Action Closing Prosecution mailed Sep. 19, 2013 (38 pages).
67 Reexamination No. 95/001,933, Third Party's Sep. 5, 2012 Comments on First Office Action mailed Jun. 5, 2012 (210 pages).
68 Reexamination No. 95/001,955, Appendix 19 to Request for Inter Partes Reexamination of U.S. Patent No. 8,061,359, Opening Claim Construction Brief of Defendant Hologic, Inc., dated Feb. 24, 2012, in Smith & Nephew, Inc. v. Hologic, Inc., Civil Action No. 11-12064-RWZ, U.S. District Court for the District of Massachusetts (24 pages).
69 Reexamination No. 95/001,955, Appendix 20 to Request for Inter Partes Reexamination of U.S. Patent No. 8,061,359, Opening Markman Brief of Plaintiff Smith & Nephew, Inc., dated Feb. 24, 2012, in Smith & Nephew, Inc. v. Hologic, Inc., Civil Action No. 11-12064-RWZ, U.S. District Court for the District of Massachusetts (24 pages).
70 Reexamination No. 95/001,955, Appendix 28 to Request for Inter Partes Reexamination of U.S. Patent No. 8,061,359, Claim chart for anticipation of claims 1-8 based on U.S. Patent No. 5,456,689 to Kresch (4 pages).
71 Reexamination No. 95/001,955, Appendix 29 to Request for Inter Partes Reexamination of U.S. Patent No. 8,061,359, Claim chart for anticipation of claims 1-8 based on U.S. Patent No. 6,032,673 to Savage (13 pages).
72 Reexamination No. 95/001,955, Appendix 30 to Request for Inter Partes Reexamination of U.S. Patent No. 8,061,359, Claim chart for anticipation of claims 1-8 based on U.S. Patent No. 3,945,375 to Banko (4 pages).
73 Reexamination No. 95/001,955, Decision Denying Petition mailed Sep. 28, 2012 (5 pages).
74 Reexamination No. 95/001,955, Executed Expert Declaration of Dr. Henry A. Dominicis in support of Request for Inter Partes Reexamination of U.S. Patent No. 8,061,359, Executed Apr. 1, 2012 (150 pages).
75 Reexamination No. 95/001,955, Executed Expert Declaration of Hal Walbrink in support of Request for Inter Partes Reexamination of U.S. Patent No. 8,061,359, Executed Apr. 2, 2012 (22 pages).
76 Reexamination No. 95/001,955, Litigation Search Report CRU 3999 dated Apr. 3, 2012 (33 pages).
77 Reexamination No. 95/001,955, Order Denying Request for Inter Partes Reexamination mailed Jun. 4, 2012 (35 pages).
78 Reexamination No. 95/001,955, Request for Inter Partes Reexamination of U.S. Patent No. 8,061,359, filed Apr. 2, 2012 (265 pages).
79 Reexamination No. 95/001,955, Request for Reconsideration of Third Party Requestor's Petition for Reexamination mailed Jul. 3, 2012 (32 pages).
80 Reexamination No. 95/002,058, Executed Expert Declaration of Dr. Henry A. Dominicis in support of Request for Inter Partes Reexamination of U.S. Patent No. 8,061,359, Executed Jul. 24, 2012 (101 pages).
81 Reexamination No. 95/002,058, First Action Closing Prosecution mailed Aug. 9, 2013 (34 pages).
82 Reexamination No. 95/002,058, First Office Action mailed Sep. 19, 2012 (37 pages).
83 Reexamination No. 95/002,058, Litigation Search Report CRU 3999 dated Aug. 13, 2012 (29 pages).
84 Reexamination No. 95/002,058, Patent Owner's Jan. 22, 2013 Response to First Office Action mailed Sep. 19, 2012 (379 pages).
85 Reexamination No. 95/002,058, Patent Owner's Mar. 24, 2014 Response to Second Office Action mailed Jan. 24, 2014 (55 pages).
86 Reexamination No. 95/002,058, Patent Owner's Mar. 5, 2015 Notice of Appeal (2 pages).
87 Reexamination No. 95/002,058, Patent Owner's Sep. 29, 2014 Response to Second Action Closing Prosecution mailed Aug. 27, 2014 (12 pages).
88 Reexamination No. 95/002,058, Patent Owner's Sep. 9, 2013 Response to First Action Closing Prosecution dated Aug. 9, 2013 (159 pages).
89 Reexamination No. 95/002,058, Reexam Order mailed Sep. 19, 2012 (54 pages).
90 Reexamination No. 95/002,058, Right of Appeal Notice mailed Feb. 4, 2015 (35 pages).
91 Reexamination No. 95/002,058, Second Action Closing Prosecution mailed Aug. 27, 2014 (35 pages).
92 Reexamination No. 95/002,058, Second Office Action mailed Jan. 24, 2014 (31 pages).
93 Reexamination No. 95/002,058, Third Party's Apr. 23, 2014 Comments on Second Office Action mailed Jan. 24, 2014 (117 pages).
94 Reexamination No. 95/002,058, Third Party's Feb. 21, 2013 Comments on First Office Action mailed on Sep. 19, 2012 (771 pages).
95 Reexamination No. 95/002,058, Third Party's Jul. 24, 2012 Request for Inter Partes Reexamination of U.S. Patent No. 8,061,359 (1050 pages).
96 Reexamination No. 95/002,058, Third Party's Oct. 19, 2012 Request for Reconsideration of Certain Decisions Regarding Third Party Requestor's Request for Reexamination of U.S. Patent No. 8,061,359 (19 pages).
97 Reexamination No. 95/002,058, Third Party's Oct. 29, 2014 Comments on Second Action Closing Prosecution mailed Aug. 27, 2014 (31 pages).
98 Reexamination No. 95/002,058, Third Party's Oct. 9, 2013 Comments on First Action Closing Prosecution mailed Aug. 9, 2013 (25 pages).
99 Reference AQ "Fishing Reel produced and sold by Shimano of Japan in to the U.S. prior to Oct. 26, 2001," as cited in the IDS filed Oct. 17, 2005 in the prosecution file history of U.S. Appl. No. 09/983,810 (7 pages).
100 Richard Wolf "'Morce-Power 2306' Electronic Morcellator" (2 pages).
101 Richard Wolf "The Fluid Manager" (2 pages).
102 Sheth, "Fiberoptic Light for Oophorectomy at Vaginal Hysterectomy", Journal of Gynecologic Surgery, vol. 14, No. 3, pp. 119-122, 1998 (4 pages).
103 Sugimoto "A Color Atlas of Hysteroscopy" Springer-Verlag Tokyo, 1999 (17 pages).
104 U.S. Appl. No. 09/486,977, Office Action mailed Sep. 7, 2005 (7 pages).
105 U.S. Appl. No. 11/780,759, Applicant's Mar. 31, 2011 Response to Office Action mailed Jan. 5, 2010 (15 pages).
106 U.S. Appl. No. 11/780,759, Applicant's Oct. 25, 2010 Response to Office Action mailed Jul. 26, 2010 (13 pages).
107 U.S. Appl. No. 11/780,759, Office Action mailed Jan. 5, 2011 (7 pages).
108 U.S. Appl. No. 11/780,759, Office Action mailed Jul. 22, 2010 (5 pages).
109 U.S. Appl. No. 11/780,759, Office Action mailed Jul. 26, 2010 (7 pages).
110 U.S. Appl. No. 11/929,938, Office Action mailed Jan. 5, 2011 (10 pages).
111 U.S. Appl. No. 11/929,938, Office Action mailed Jul. 30, 2010 (10 pages).
112 U.S. Appl. No. 11/929,940, Advisory Action mailed Sep. 10, 2010 (3 pages).
113 U.S. Appl. No. 11/929,940, Office Action mailed Dec. 30, 2009 (9 pages).
114 U.S. Appl. No. 11/929,940, Office Action mailed Jul. 1, 2010 (12 pages).
115 Valle "Hysteroscopic Removal of Submucous Leiomyomas", Journal of Gynecologic Surgery, vol. 6, No. 1, pp. 89-96, 1990 (9 pages).
116 Weck "A Direct Path to Diagnostic and Operative Control: The Weck-Baggish Hysteroscopy System" Advertisement, Journal of Gynecologic Surgery, vol. 7, No. 1, 1991 (2 pages).
117 Williamson et al., Editorial 1 "Complications of hysteroscopic treatments of menorrhagia", British Journal of Anesthesia, vol. 77, No. 3, pp. 305-308, 1996 (4 pages).
Clasificación internacional A61B1/00, A61B1/018, A61B17/32, A61B1/12, A61B1/015, A61B17/34
Clasificación cooperativa A61B1/018, A61B1/00068, A61B2017/0225, A61B17/320016, A61B17/0218, A61B2017/3445, A61B2017/320024, A61B17/3498, A61B1/015, A61B17/3421
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SHENER, CEMAL;NEWELL, CHRISTOPHER R.;HEDSTROM, PETTER;AND OTHERS;SIGNING DATES FROM 20040820 TO 20040824;REEL/FRAME:033647/0546